Medcom Tech Osake

Medcom Tech Velat/EBITDA

Delisted

Kokonaisvelka suhteessa EBITDA:han yhtiöstä Medcom Tech (MED.MC) 22.8.2026 päivämäärällä on 12,31. Edellisenä vuonna Kokonaisvelka suhteessa EBITDA:han oli 12,45 — muutos −1,09 % (matalampi).

Velat/EBITDA

12,31

YoY

−1,09%

Viimeksi päivitetty:

Kokonaisvelka suhteessa EBITDA:han yhtiöstä Medcom Tech on 2026 12,31 . Kokonaisvelka suhteessa EBITDA:han yhtiöstä Medcom Tech oli 2025 12,45 . Se laskee −1,09% matalampi edelliseen vuoteen verrattuna.

Medcom Tech Velat/EBITDA historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

Velat/EBITDA
Date
Velat/EBITDA
1.1.2015
55,28 EUR
1.1.2016
45,28 EUR
1.1.2017
−78,01 EUR
1.1.2018
−1,65 EUR
1.1.2019
0,81 EUR
1.1.2020
2 437,63 EUR
1.1.2021
12,45 EUR
1.1.2022
12,31 EUR
Medcom Tech Velat/EBITDA historia
VUOSIVelat/EBITDAYoY
12,31−1,09%
12,45−99,49%
2 437,63+300 107,45%
0,81−149,20%
−1,65−97,88%
−78,01−272,29%
45,28−18,10%
55,28+772,56%
6,34
Access this data via the Eulerpool API

Medcom Tech Osakeanalyysi

Mitä Medcom Tech tekee? Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Medcom Tech osakkeesta

Yhtiön Medcom Tech Kokonaisvelka suhteessa EBITDA:han on 12,31 vuonna 2026.

Kokonaisvelka suhteessa EBITDA:han yhtiöstä Medcom Tech muuttui arvosta 12,45 arvoon 12,31, mikä edustaa −1,09 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää Kokonaisvelka suhteessa EBITDA:han Medcom Tech:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Velka/EBITDA mittaa kokonaisvelkaa suhteessa tulokseen ennen korkoja, veroja ja poistoja. Se osoittaa, kuinka monella vuodella kaikki velat voitaisiin maksaa takaisin EBITDA:sta.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata Kokonaisvelka suhteessa EBITDA:han:n Medcom Tech alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Vipuvaikutus — Medcom Tech

Kaikki tunnusluvut — Medcom Tech